Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • AlphaLISA assays for immune checkpoint detection and quantitation
quantitation1920x640
Technical Note

AlphaLISA assays for immune checkpoint detection and quantitation

Quantifying Immune Checkpoints: AlphaLISA Biomarker Detection Kits.

This technical note focuses on the role of checkpoint molecules in cancer immunotherapies. Checkpoint molecules are molecular markers that can regulate an immune system attack on cancer cells. They have gained prominence as promising candidates for immunotherapies. AlphaLISA detection kits are designed to detect and quantify the levels of these molecules in cell culture media, serum, and cell lysates.

For research use only. Not for use in diagnostic procedures.

Download Resource

AlphaLISA assays for immune checkpoint detection and quantitation

Download Technical Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.